Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24-week interim data of the Phase 3 MYR301 study

H Wedemeyer, S Aleman, M Brunetto, A Blank, P Andreone, P Bogomolov, V Chulanov, N Mamonova, N Geyvandova, V Morozov, O Sagalova, T Stepanova, D Manuilov, V Suri, Q An, JF Flaherty, A Osinusi, J zur Wiesch Schulze, M Cornberg, S Zeuzem, P Lampertico · Zeitschrift für Gastroenterologie · 2022 · Heft 08 · S. e471-e472